Integ. Proteins

{
  "main_header": {
    "sid": 354640,
    "name": "Integ. Proteins",
    "stock_name": "Integ. Proteins",
    "full_name": "Integrated Proteins Ltd",
    "name_url": "stocks-analysis/integ-proteins",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.99",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "31.99",
    "mcapval": "60.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 519606,
    "symbol": "",
    "ind_name": "Edible Oil",
    "ind_code": 92,
    "indexname": "",
    "isin": "INE177M01013",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "2 ",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/integ-proteins-354640-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Integrated Proteins Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/integrated-proteins-ltd-is-rated-strong-sell-3784465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IntegratedProte_mojoScore_3784465.png",
        "date": "2026-01-07 10:10:23",
        "description": "Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Integrated Proteins Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/integrated-proteins-ltd-is-rated-strong-sell-3769594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IntegratedProte_mojoScore_3769594.png",
        "date": "2025-12-25 15:13:16",
        "description": "Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Integ. Proteins falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-integ-proteins-fallingrising-3757845",
        "imagepath": "",
        "date": "2025-12-13 01:19:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock opened sharply lower on 12-Dec, registering a gap down of nearly 5%, and remained at this intraday low throughout the trading session. This performance starkly contrasts with the broader Solvent Extraction sector, which gained 4.37% on the same day. Over the past week and month, Integrated Proteins has declined by 5.61% and 10.33% respectively, while the Sensex has posted modest gains of 0.52% and 0.95% over the same periods. Year-to-date, the stock has plummeted by over 54%, a stark underperformance compared to the Sensex’s 9.12% rise. Even over the last year, the stock’s return of -46.62% contrasts sharply with the Sensex’s positive 4.89%.</p>\n<p><strong>Trading Activity and Investor Participation</strong></p>\n<p>Investo..."
      },
      {
        "title": "Integ. Proteins Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/integ-proteins-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3755075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IntegProteins_mojoScore_3755075.png",
        "date": "2025-12-10 10:10:40",
        "description": "Integ. Proteins, a microcap player in the edible oil sector, has undergone a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. This adjustment highlights ongoing challenges in the company’s financial performance and market positioning, underscoring the need for investors to carefully consider the evolving landscape."
      },
      {
        "title": "Integrated Proteins Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/integrated-proteins-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3746769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IntegratedProte_only_sellers_3746769.png",
        "date": "2025-12-04 12:41:00",
        "description": "Integrated Proteins Ltd has encountered significant selling pressure on 4 December 2025, with the stock opening sharply lower and trading exclusively at its intraday low. The absence of buyers and persistent downward momentum highlight distress selling signals, marking a challenging phase for the edible oil company amid broader market fluctuations."
      },
      {
        "title": "Is Integ. Proteins overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-integ-proteins-overvalued-or-undervalued-3734480",
        "imagepath": "",
        "date": "2025-11-28 08:07:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Attractive Pricing</strong></p>\n<p>At a price of ₹38.25, Integ. Proteins trades with a price-to-earnings (PE) ratio of 42.6, which might appear elevated at first glance. However, this figure must be contextualised within the company’s broader valuation framework. The price-to-book (P/B) ratio stands at a notably low 0.69, suggesting the stock is trading below its book value, a classic indicator of undervaluation in asset terms.</p>\n<p>Further, the enterprise value (EV) multiples provide additional insight. The EV to EBIT and EV to EBITDA ratios both hover around 14.06, which is moderate relative to industry standards. More strikingly, the EV to sales ratio is just 0.55, indicating the market values the company at just over half its annual sales, a conservative valu..."
      },
      {
        "title": "Integrated Proteins Faces Intense Selling Pressure Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/integrated-proteins-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3733815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IntegratedProte_only_sellers_3733815.png",
        "date": "2025-11-27 14:51:27",
        "description": "Integrated Proteins Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the edible oil company as it continues to face consecutive losses and a significant downtrend over the past year."
      },
      {
        "title": "Is Integ. Proteins overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-integ-proteins-overvalued-or-undervalued-3687525",
        "imagepath": "",
        "date": "2025-11-11 08:08:26",
        "description": "As of 10 November 2025, the valuation grade for Integ. Proteins has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 42.60, an EV to EBIT of 14.06, and a PEG ratio of 0.11, all suggesting that the stock may be trading below its intrinsic value relative to its earnings growth potential.\n\nWhen compared to peers, Integ. Proteins stands out as attractive against Manorama Industries, which is deemed expensive with a PE of 43.52, and CIAN Agro, also expensive at a PE of 50.51. Additionally, the company's recent stock performance has been strong, with a 1-month return of 65.58%, significantly outperforming the Sensex's 1.25% return, reinforcing the notion that Integ. Proteins is undervalued in the current market landscape...."
      },
      {
        "title": "How has been the historical performance of Integ. Proteins?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-integ-proteins-3683593",
        "imagepath": "",
        "date": "2025-11-09 22:43:25",
        "description": "Answer:\nThe historical performance of Integ. Proteins shows significant growth in net sales, reaching 21.50 Cr in March 2025, up from just 0.24 Cr in March 2024 and 0.17 Cr in March 2023. The total operating income also increased to 21.50 Cr in March 2025, compared to 0.24 Cr in the previous year. The company has seen a notable rise in operating profit, which stood at 0.34 Cr in March 2025, a substantial improvement from 0.14 Cr in March 2024. Profit before tax also increased to 0.32 Cr in March 2025, up from 0.10 Cr in March 2024, while profit after tax reached 0.25 Cr, compared to 0.09 Cr in the prior year. The earnings per share (EPS) rose to 0.71 in March 2025 from 0.26 in March 2024, reflecting a positive trend in profitability.\n\nBreakdown:\nInteg. Proteins has demonstrated a remarkable upward trajectory in its financial performance over the past few years. Starting from no sales in previous years, the ..."
      }
    ],
    "total": 186,
    "sid": "354640",
    "stock_news_url": "https://www.marketsmojo.com/news/integrated-proteins-354640"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th December 2025",
      "datetime": "30-Dec-2025",
      "details": "Pursuant to Regulation 30 and Schedule III SEBI(LODR) we hereby inform of the resignation of the company secretary and appointment of a new company secretary",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR)-Appointment Of Company Secretary And Compliance Officer",
      "datetime": "30-Dec-2025",
      "details": "Intimation under Regulation 30 of SEBI(LODR) for appointment of a company secretary wef 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR)-Resignation Of Company Secretary And Compliance Officer",
      "datetime": "30-Dec-2025",
      "details": "Intimation under regulation 30 od SEBI(LODR) for resignation of company secretary wef 30th December 2025 and appointment of a company secretary wef 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Integrated Proteins Ltd is Rated Strong Sell

2026-01-07 10:10:23

Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Integrated Proteins Ltd is Rated Strong Sell

2025-12-25 15:13:16

Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Integ. Proteins falling/rising?

2025-12-13 01:19:40

Recent Price Movement and Market Comparison

The stock opened sharply lower on 12-Dec, registering a gap down of nearly 5%, and remained at this intraday low throughout the trading session. This performance starkly contrasts with the broader Solvent Extraction sector, which gained 4.37% on the same day. Over the past week and month, Integrated Proteins has declined by 5.61% and 10.33% respectively, while the Sensex has posted modest gains of 0.52% and 0.95% over the same periods. Year-to-date, the stock has plummeted by over 54%, a stark underperformance compared to the Sensex’s 9.12% rise. Even over the last year, the stock’s return of -46.62% contrasts sharply with the Sensex’s positive 4.89%.

Trading Activity and Investor Participation

Investo...

Read full news article

Integ. Proteins Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-10 10:10:40

Integ. Proteins, a microcap player in the edible oil sector, has undergone a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. This adjustment highlights ongoing challenges in the company’s financial performance and market positioning, underscoring the need for investors to carefully consider the evolving landscape.

Read full news article

Integrated Proteins Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-04 12:41:00

Integrated Proteins Ltd has encountered significant selling pressure on 4 December 2025, with the stock opening sharply lower and trading exclusively at its intraday low. The absence of buyers and persistent downward momentum highlight distress selling signals, marking a challenging phase for the edible oil company amid broader market fluctuations.

Read full news article

Is Integ. Proteins overvalued or undervalued?

2025-11-28 08:07:55

Valuation Metrics Indicate Attractive Pricing

At a price of ₹38.25, Integ. Proteins trades with a price-to-earnings (PE) ratio of 42.6, which might appear elevated at first glance. However, this figure must be contextualised within the company’s broader valuation framework. The price-to-book (P/B) ratio stands at a notably low 0.69, suggesting the stock is trading below its book value, a classic indicator of undervaluation in asset terms.

Further, the enterprise value (EV) multiples provide additional insight. The EV to EBIT and EV to EBITDA ratios both hover around 14.06, which is moderate relative to industry standards. More strikingly, the EV to sales ratio is just 0.55, indicating the market values the company at just over half its annual sales, a conservative valu...

Read full news article

Integrated Proteins Faces Intense Selling Pressure Amidst Prolonged Downtrend

2025-11-27 14:51:27

Integrated Proteins Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the edible oil company as it continues to face consecutive losses and a significant downtrend over the past year.

Read full news article

Is Integ. Proteins overvalued or undervalued?

2025-11-11 08:08:26

As of 10 November 2025, the valuation grade for Integ. Proteins has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 42.60, an EV to EBIT of 14.06, and a PEG ratio of 0.11, all suggesting that the stock may be trading below its intrinsic value relative to its earnings growth potential. When compared to peers, Integ. Proteins stands out as attractive against Manorama Industries, which is deemed expensive with a PE of 43.52, and CIAN Agro, also expensive at a PE of 50.51. Additionally, the company's recent stock performance has been strong, with a 1-month return of 65.58%, significantly outperforming the Sensex's 1.25% return, reinforcing the notion that Integ. Proteins is undervalued in the current market landscape....

Read full news article

How has been the historical performance of Integ. Proteins?

2025-11-09 22:43:25

Answer: The historical performance of Integ. Proteins shows significant growth in net sales, reaching 21.50 Cr in March 2025, up from just 0.24 Cr in March 2024 and 0.17 Cr in March 2023. The total operating income also increased to 21.50 Cr in March 2025, compared to 0.24 Cr in the previous year. The company has seen a notable rise in operating profit, which stood at 0.34 Cr in March 2025, a substantial improvement from 0.14 Cr in March 2024. Profit before tax also increased to 0.32 Cr in March 2025, up from 0.10 Cr in March 2024, while profit after tax reached 0.25 Cr, compared to 0.09 Cr in the prior year. The earnings per share (EPS) rose to 0.71 in March 2025 from 0.26 in March 2024, reflecting a positive trend in profitability. Breakdown: Integ. Proteins has demonstrated a remarkable upward trajectory in its financial performance over the past few years. Starting from no sales in previous years, the ...

Read full news article

View All News